The health authority also considers that the administration of a reminder dose to fragile adolescents aged 12 to 17 “can be considered”.
Le Monde with AFP and Reuters
On the eve of the end-of-year celebrations and because of the propagation of the Omicron Variant, the High Authority of Health (HAS) recommended, in A review Published Friday 24 December , to reduce the deadline between the primovaccination against CVIV-19 and its reminder.
While France recorded, Thursday, its absolute record in number of cases detected – more than 90,000 in twenty-four hours – the objective of this recommendation is twofold, explains the has: “to limit the maximum Number of new cases of infection and serious shapes and avoid the saturation of health facilities. “
Indeed, first studies “suggest that vaccines (…) are effective against non-serious symptomatic forms of the Omicron variant at 80% to one, two months, but faster their effectiveness”, still explains the statement. Four months after a Primovaccination with the Pfizer-Biontech vaccine, the protection would fall to 34%.
The instance also considers that the administration of a reminder dose to fragile adolescents aged 12 to 17 “can be considered”. These were not necessarily concerned by the recall campaign.
The Minister of Health, Olivier Véran, announced In a tweet on Friday, that the time between Primovaccination and Reminder was already brought back to four months. Before the family gatherings, the minister recalled that 100,000 vaccination appointments were still available on this Christmas Eve and a million additional slots should be open next week.